Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies

Vaccination against SARS-CoV-2 just started in most of the countries. However, the development of specific vaccines against SARS-CoV-2 is not the only approach to control the virus and monoclonal antibodies (mAbs) start to merit special attention as a therapeutic option to treat COVID-19 disease. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Martí, Didac, Alsina, Marc, Alemán, Carlos, Bertran, Oscar, Turon, Pau, Torras, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545699/
https://www.ncbi.nlm.nih.gov/pubmed/34710552
http://dx.doi.org/10.1016/j.biochi.2021.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545699/
https://www.ncbi.nlm.nih.gov/pubmed/34710552
http://dx.doi.org/10.1016/j.biochi.2021.10.013

Ejemplares similares